INDOUSNSEIndo Us Biotech LimitedLowNeutral
Announced Wed, 1 Oct · 22:36 IST

Revised Voting Results wIith Consolidated Scrutinizer Report

Board & Shareholder Meetings View source PDF

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Indo Us Biotech Limited has filed a revised voting results report along with a consolidated scrutinizer's report on the NSE. This type of filing is typically submitted after a shareholder meeting (AGM or EGM) to disclose how shareholders voted on the resolutions put before them. The word 'revised' indicates this is an updated version of an earlier voting results filing, likely correcting or consolidating previously disclosed data. The scrutinizer's report is an independent verification of the voting outcome, lending credibility to the declared results. No specific vote counts or resolution details are available in the headline itself.

Likely market impact

For shareholders, this confirms that the company has formally closed out the voting process for a recent meeting with a verified, audited outcome. A revised filing usually has no direct bearing on share price unless it reveals that a key resolution was defeated or required renegotiation, which would warrant closer attention.